Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) EPS (Weighted Average and Diluted) (2020 - 2025)

Beauty Health (SKIN) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$0.09 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 18.18% to -$0.09 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.16, a 58.97% increase, with the full-year FY2024 number at -$0.36, up 52.63% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.09 for Q3 2025 at Beauty Health, down from $0.06 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q2 2025 to a low of -$1.63 in Q3 2021.
  • A 5-year average of -$0.28 and a median of -$0.1 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 917854.54% in 2021, then soared 160.0% in 2025.
  • Beauty Health's EPS (Weighted Average and Diluted) stood at -$0.37 in 2021, then surged by 97.3% to -$0.01 in 2022, then plummeted by 700.0% to -$0.08 in 2023, then surged by 37.5% to -$0.05 in 2024, then crashed by 80.0% to -$0.09 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's EPS (Weighted Average and Diluted) are -$0.09 (Q3 2025), $0.06 (Q2 2025), and -$0.08 (Q1 2025).